Skip to contentSkip to filters

We use cookies for analytics.

GLP-1 targets beyond obesity, and misusing brain data

Related content

About

Investigative journalist Jonathan Moens describes how companies selling consumer-grade brain-wave headsets for sleep, focus and meditation collect users’ neural data, including as training data for AI models, often without consent. Science senior editor Yevgeniya Nusinovich then surveys uses of GLP-1 receptor agonists beyond weight loss, from cognition to cancer, and Nora Volkow, director of the US National Institute on Drug Abuse, discusses prospects for GLP-1 therapies against addiction to a range of substances.

Topics

Details

Show

Science Magazine Podcast

12 episodes on World Wide · Science / AAAS